Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

VNRX - VolitionRX Ltd


Close
0.72
0.043   6.014%

Share volume: 64,701
Last Updated: Fri 30 Aug 2024 10:30:00 PM CEST

PREVIOUS CLOSE
CHG
CHG%

$0.68
0.04
6.40%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Company vs Stock growth
vs
Performance
5 Days
20.20%
1 Month
9.09%
3 Months
5.70%
6 Months
-28.71%
1 Year
-42.40%
2 Year
-56.63%
Key data
Stock price
$0.72
P/E Ratio 
-2.05
DAY RANGE
$0.67 - $0.72
EPS 
-$0.40
52 WEEK RANGE
$0.43 - $1.38
52 WEEK CHANGE
-$0.44
MARKET CAP 
66.313 M
YIELD 
N/A
SHARES OUTSTANDING 
92.101 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/12/2024
BETA 
0.34
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$132,635
AVERAGE 30 VOLUME 
$184,237
Company detail
CEO:
Region: US
Website: volitionrx.com
Employees: 58
IPO year: -
Issue type: Common Stock
Market: NYSE American
Industry:
Sector:

volitionrx is a life sciences company whose goal is to make its non-invasive blood tests for cancer as common and simple to use as existing diabetic and cholesterol tests on similar formats. volitionrx’s development activities are currently centered in belgium with a focus on bringing its revolutionary diagnostic products to market first in europe, then the u.s. and worldwide. you can find more information about volitionrx at our website at www.volitionrx.com, on twitter at www.twitter.com/volitionrx, linkedin at http://www.linkedin.com/company/volitionrx or facebook at www.facebook.com/volitionrx.

Recent news